feed,title,long_url,short_url
gNews,Cytokinetics Stock: How Its New Drug Could Be A Safer Version Of Bristol's Camzyos - Investor's Business Daily,https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2N5dG9raW5ldGljcy1zdG9jay1vYnN0cnVjdGl2ZS1oY20tYnJpc3RvbC1teWVycy1zcXVpYmItY2Ftenlvcy_SAQA?oc=5,https://da.gd/VysO6q
